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  48 
Abstract 49 
Introduction 50 
In incidence lung cancer screening rounds, new pulmonary nodules are regular findings. They 51 
have a higher lung cancer probability than baseline nodules. Previous studies showed that 52 
baseline perifissural nodules (PFNs) represent benign lesions. Whether this is also the case for 53 
incident PFNs is unknown. This study evaluated newly detected nodules in the Dutch-Belgian 54 
randomized-controlled NELSON study with respect to incidence of fissure-attached nodules, 55 
their classification, and lung cancer probability.    56 
Method 57 
Within the NELSON trial, 7,557 participants underwent baseline screening between April 58 
2004 and December 2006. Participants with new nodules detected after baseline were 59 
included. Nodules were classified based on location and attachment. Fissure-attached nodules 60 
were re-evaluated to be classified as typical, atypical or non-PFN by two radiologists without 61 
knowledge of participant lung cancer status.  62 
Result 63 
1,484 new nodules were detected in 949 participants (77.4% male, median age 59 64 
[interquartile range: 55-63]) in the second, third and final NELSON screening round. Based 65 
on 2-year follow-up or pathology, 1,393 nodules (93.8%) were benign. In total, 97 (6.5%) 66 
were fissure-attached, including 10 malignant nodules.  None of the new fissure-attached 67 
malignant nodules was classified as a typical or atypical PFN.  68 
Conclusion 69 
In the NELSON study, 6.5% of incident lung nodules were fissure-attached. None of the lung 70 
cancers that originated from a new fissure-attached nodule in the incidence lung cancer 71 
screening rounds was classified as a typical or atypical PFN. Our results suggest that also in 72 
the case of a new PFN, it is highly unlikely that these PFNs will be diagnosed as lung cancer. 73 
 74 
INTRODUCTION (max 200 words) 75 
Pulmonary nodules are common findings in lung cancer screening and in clinical settings (1–76 
3). To increase the efficiency of lung cancer screening, it is key to timely and adequately 77 
identify high-risk nodules while preventing overdiagnosis and overtreatment. Nodule follow-78 
up and management are mainly determined based on nodule size and growth rate (4-6). 79 
Recently, it was shown that new solid pulmonary nodules detected in incidence lung cancer 80 
screening rounds comprise a higher lung cancer probability compared with baseline nodules , 81 
and require more stringent follow-up of smaller nodules (4).  82 
 83 
Twenty to thirty percent of screen-detected  nodules from baseline is classified as perifissural 84 
nodule (PFN) (5–7). Previous studies showed that baseline PFNs and PFNs in clinical settings 85 
represent non-malignant lesions such as intrapulmonary lymph nodes (8–10). Whether this 86 
also applies for new incident PFNs is unknown. To investigate this, we evaluated newly 87 
detected nodules in the Dutch-Belgian randomized-controlled NELSON study with respect to 88 
incidence of perifissural nodules, their classification and lung cancer probability. 89 
  90 
MATERIAL AND METHODS (max 350 words) 91 
The NELSON trial (trial registration number, ISRCTN63545820) was authorized by the 92 
Dutch Health Care Committee and approved by Ethics Committees of all participating centers 93 
in the Netherlands and Belgium. Written informed consent was obtained from all participants. 94 
The study protocol has been published before (11,12).  In brief, 15,792 participants between 95 
50 and 75 years of age, who had daily smoked >15 cigarettes for >25 years or >10 cigarettes 96 
for >30 years, and were still smoking or had stopped smoking less than 10 years previously 97 
were randomized (1:1). The ‘screen’ group (N=7,900) received low-dose CT scans in year 1 98 
(baseline), 2, 4 and 6.5.  99 
 100 
For the current analyses, all participants with a new nodule ≥ 15mm3 in one of the three 101 
incidence screening rounds were included. Confirmation of malignancy was based on 102 
histology. In case it was not possible to obtain histology, but a nodule was highly 103 
suspicious for malignancy because of the combination of suspicious CT appearance, fast 104 
growth rate, and positive PET-CT result, the nodule was considered malignant and was 105 
treated with stereotactic radiotherapy. Details regarding imaging acquisition/analysis and 106 
nodule measurements are provided in the Supplementary Methods section, and 107 
Supplementary References. 108 
 109 
Based on attachment, nodules were classified as vessel-attached, fissure-attached or 110 
intraparenchymal by the NELSON radiologists. All screening CT scans of participants with 111 
newly detected lung cancer were re-evaluated in retrospect by two radiologists (4 and 6 years 112 
of experience) to assess fissural attachment. Furthermore, benign and malignant fissure-113 
attached nodules were re-evaluated by classifying them as typical, atypical or non-PFN., The 114 
definition of these nodule classifications were previously given by de Hoop et al. Typical 115 
PFNs were defined as fissure-attached, homogeneous, solid nodules with smooth margins and 116 
lentiform triangular shape. Atypical PFNs were nodules that either met all features but were 117 
not attached to a visible fissure or were fissure-attached nodules that were convex on one side 118 
and round on the other side. All other fissure-attached nodules with a shape that did not 119 
appear to be influenced by the fissure were defined as non-PFN  (13).  During the evaluation, 120 
the radiologists were blinded with regards to outcome of the nodules (either based on 121 
histology, or stability in nodule size during two-year follow-up). In case of disagreement, a 122 
third radiologist (13 years of experience) arbitrated.  123 
 124 
Statistical analysis 125 
Normally distributed variables are described as mean and standard deviation. Otherwise, the 126 
median and interquartile range are presented. Mann-Whitney U test was used to analyze 127 
continuous, non-parametric independent data. Chi-Square test was used for the analysis of 128 
categorical data. Statistical significance was considered for p < 0.05 and all tests were 2-129 
tailed. For the statistical analysis, SPSS version 25 was used. 130 
  131 
RESULTS (max 350 words) 132 
In the three NELSON incidence screening rounds, 1,484 new solid nodules were detected in 133 
949 participants. Of these, 107 (7%) nodules in 104 participants were registered as fissure-134 
attached by the NELSON radiologists, and these were selected for re-evaluation. Because CT 135 
images from four participants were not retrievable, and six nodules were rated as not fissure-136 
attached in the re-evaluation, the final number of re-evaluated fissure-attached nodules was 137 
97, from 95 participants (Figure 1).  138 
 139 
 140 
Figure 1. Flowchart of new fissure-attached nodules in the NELSON trial 141 
 142 
Median age of the participants with new fissure-attached nodules was 58 years (IQR, 63-55) 143 
and 67 (71%) were male. Overall, 55 (58%) participants were current smoker with a median 144 
of 38 pack-years (IQR: 49-28). Of the new fissure-attached nodules, 32 (33%) were detected 145 
in the second screening round, 44 (45%) were detected in the third screening round and 21 146 
(22%) nodules were detected in the final screening round. No significant difference was found 147 
in age (p = 0.45), gender (p = 0.08), and pack years (p = 0.44) between the study cohort and 148 
the larger study population of screenees with new solid lung nodules at incidence screening 149 
rounds (949 participants). 150 
 151 
Table 1. Size, location, and appearance of fissure-attached nodules 152 
 PFNs (all benign) Benign non-PFNs Malignant non-
PFNs 
P value a 
Total (n) 58 (60%) 29 (30%) 10 (10%)  
Nodule size b  
Volume (IQR) 
 
19 mm3 (14) 
 
51 mm3 (250) 
 
108 mm3 (1128) 
 
< 0.03 
Mean diameter (IQR) 4 mm (1) 5 mm (5) 6 mm (9) < 0.01 
Location (n)     
Right oblique  16 (28%) 11 (38%) 5 (50%)  
0.423 
 
Horizontal  13 (22%) 6 (21%) 1 (10%) 
Left oblique  26 (45%) 10 (34%) 3 (30%) 
Accessory  3 (5%) 2 (7%) 1 (10%) 
Appearance (n)     
Lentiform 12 (21%) 0 0  
< 0.01 Triangular 30 (52%) 0 0 
Other 16 (27%) 29 (100%) 10 (100%) 
n, number of nodules; IQR, interquartile range; PFN, perifissural nodule (including both 153 
typical and atypical perifissural nodules). 154 
a Comparison between PFNs and Malignant non-PFNs 155 
b Missing values were excluded from the analysis 156 
 157 
 158 
In the 97 fissure-attached nodules that were re-evaluated, 42 (43%) were typical PFNs and 16 159 
(17%) were atypical PFNs. Thirty-nine (40%) nodules were classified as non-PFN. Among 160 
Formatted: Font: (Default) Times New Roman
the non-PFNs, 10 (10%) were malignant (Table 1). Malignant non-PFNs were significantly 161 
larger than PFNs and benign non-PFNs (p < 0.03), while location did not differ (p = 0.423). In 162 
contrast to malignant and benign non-PFNs, PFNs were lentiform or triangular in appearance.  163 
There was no malignant nodule classified as PFN (Figure 2).   164 
 165 
Of the 10 malignant fissure-attached nodules, seven were located in the right lung. Four 166 
malignant nodules were located in the upper lobe, one in the middle lobe, and five were 167 
located in the lower lobe. The median volume was 108 mm3 (IQR, 1183-55; range, 37-2793) 168 
and median diameter was 6 mm (IQR, 14-5; range, 5-20). Two of the malignant nodules were 169 
large cell carcinomas, four were adenocarcinomas and one was small cell carcinoma, the 170 
malignancy of the other three nodules did not have histological diagnosis, but were regarded 171 
malignant based on their suspicious appearance, fast growth and positive PET-CT. 172 
 173 
 174 
Figure 2. Transverse images of new malignant fissure-attached nodules. Nodule (a) and (g) 175 
were large cell carcinomas. Nodule (d), (f), (i), and (j) were adenocarcinomas. Nodule (e) was 176 
a small cell carcinoma. (b), (c), and (h) were treated as lung cancers (without histological 177 
diagnosis) with stereotactic radiotherapy because of suspicious appearance, fast growth and 178 
positive PET-CT. 179 
 180 
DISCUSSION (max 450 words) 181 
To the best of our knowledge, this is the first study focusing on new perifissural nodules 182 
detected in CT lung cancer screening. A total of 97 new solid fissure-attached nodules were 183 
identified, 6.5% of all incident screen-detected lung nodules. Sixty percent of all new fissure-184 
attached nodules met the criteria of PFN. None of the malignant nodules were classified as 185 
PFN. This suggests that PFNs, even in the case of newly developed nodules, are benign 186 
findings.  187 
  188 
The prevalence of PFN nodules from the total number of new solid nodules in the NELSON 189 
study was 4% (58/1484). This percentage is considerably lower compared to the previously 190 
reported prevalence of baseline PFNs detected in a lung cancer screening setting. De Hoop et 191 
al. reported that 20% of all baseline nodules were typical PFNs and 3% were atypical, Ahn et 192 
al. reported that 28% of non-calcified nodules (NCN) were PFNs (5), and more recently Mets 193 
et al. reported that outside a lung cancer screening setting, PFNs represent 21% of the non-194 
calcified nodules (7). All these studies showed a 0% risk of malignancy in PFNs. Since PFNs 195 
are likely to be intrapulmonary lymph nodes, they may appear less frequently as new nodule 196 
in incidence screening rounds than in the baseline round.  197 
 198 
Although in our study none of the nodules classified as PFNs turned out to be lung cancer, 199 
Scheurder et al. have reported that 0.9% of nodules (five of 533) classified as typical PFNs 200 
were lung cancers. Moreover, 4.8% of atypical PFNs (16 of 332) were lung cancers (14). The 201 
difference with our result may be explained by  the fact that their dataset from the NLST was 202 
enriched with malignant nodules (70 cancers and 246 benign nodules) therefore the true 203 
misclassification rate could be far lower than the reported values. Moreover, the difference in 204 
the study designs, as they did not limit their study to only fissure attached nodules, could have 205 
further contributed to the misclassification of malignant nodules as PFN. Finally, in the 206 
NELSON study, the first MDCT systems with isotropic volume reconstruction were used, 207 
which could also explain the superior display of nodule morphology and location. 208 
 209 
A limitation of our study is the relatively small number of new fissure-attached nodules 210 
detected, although our study represents one of the largest lung cancer screening trials 211 
worldwide. Furthermore, although all malignant new nodules have been re-evaluated, a small 212 
number of benign perifissural nodules could not be re-classified into typical, atypical or non-213 
PFN since the CT scans were not retrievable.  214 
  215 
In conclusion, in the NELSON study, none of the lung cancers originating from a new nodule 216 
was classified as a typical or atypical PFN. Our results suggest that also in the case of a new 217 
PFN, it is highly unlikely that it will be diagnosed as lung cancer. This implies that short-term 218 
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